25 LLC’s Colgate-Palmolive CL Stock Holding History

25 LLC’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,460	Closed	-$111K	–	132
2023 Q2	$111K	Buy	1,460 +22	+2%	+$1.7K	0.06%	58
2023 Q1	$116K	Buy	+1,438	New	+$107K	0.07%	51

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

25 LLC's CL Position: Q3 2023 in Review

25 LLC sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 1,460 shares — an estimated $111K sold.

25 LLC first reported a position in CL in Q1 2023 and held it in 2 quarters. The position peaked at $116K in Q1 2023. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

25 LLC reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
25 LLC sold 1,460 Colgate-Palmolive shares in Q3 2023, an estimated $111K.
25 LLC first reported a position in Colgate-Palmolive in Q1 2023 and held it in 2 quarters.
25 LLC's Colgate-Palmolive position peaked at $116K in Q1 2023.
1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.